SearchDictionaryMobileLogin

Kay-Tee Khaw Selected Research

Neoplasms (Cancer)

10/2008Lack of Prospective Associations between Plasma and Urinary Phytoestrogens and Risk of Prostate or Colorectal Cancer in the European Prospective into Cancer-Norfolk Study.
06/2008Evaluation of the Framingham risk score in the European Prospective Investigation of Cancer-Norfolk cohort: does adding glycated hemoglobin improve the prediction of coronary heart disease events?
06/2008Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC).
05/2008Dietary fat intake and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition.
02/2008Circulating concentrations of folate and vitamin B12 in relation to prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition study.
01/2008Plasma vitamin C concentrations predict risk of incident stroke over 10 y in 20 649 participants of the European Prospective Investigation into Cancer Norfolk prospective population study.
01/2008Breast cancer risk in relation to urinary and serum biomarkers of phytoestrogen exposure in the European Prospective into Cancer-Norfolk cohort study.
12/2007Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study.
10/2007Dietary carbohydrates, glycemic index, glycemic load, and endometrial cancer risk within the European Prospective Investigation into Cancer and Nutrition cohort.
09/2007Serum androgens and prostate cancer among 643 cases and 643 controls in the European Prospective Investigation into Cancer and Nutrition.
09/2007Plasma carotenoids, retinol, and tocopherols and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition study.
09/2007Metabolic syndrome, plasma lipid, lipoprotein and glucose levels, and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC).
07/2007Serum C-peptide, IGFBP-1 and IGFBP-2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition.
06/2007Serum levels of C-peptide, IGFBP-1 and IGFBP-2 and endometrial cancer risk; results from the European prospective investigation into cancer and nutrition.
05/2007Usual physical activity and endogenous sex hormones in postmenopausal women: the European prospective investigation into cancer-norfolk population study.
03/2007Serum IGF-I, its major binding protein (IGFBP-3) and epithelial ovarian cancer risk: the European Prospective Investigation into Cancer and Nutrition (EPIC).
03/2007Haplotype-based analysis of common variation in the acetyl-coA carboxylase alpha gene and breast cancer risk: a case-control study nested within the European Prospective Investigation into Cancer and Nutrition.
02/2007Glycated hemoglobin and risk of stroke in people without known diabetes in the European Prospective Investigation into Cancer (EPIC)-Norfolk prospective population study: a threshold relationship?
01/2007Endogenous androgens and risk of epithelial ovarian cancer: results from the European Prospective Investigation into Cancer and Nutrition (EPIC).
12/2006Polymorphisms in metabolic genes related to tobacco smoke and the risk of gastric cancer in the European prospective investigation into cancer and nutrition.
12/2006Ethanol intake and risk of lung cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC).
11/2006Plasma and dietary vitamin C levels and risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST).
08/2006Serum C-peptide levels and breast cancer risk: results from the European Prospective Investigation into Cancer and Nutrition (EPIC).
05/2006No association between polymorphisms in CYP2E1, GSTM1, NAT1, NAT2 and the risk of gastric adenocarcinoma in the European prospective investigation into cancer and nutrition.
12/2005Plasma ascorbic acid concentrations and fat distribution in 19,068 British men and women in the European Prospective Investigation into Cancer and Nutrition Norfolk cohort study.
10/2005Genetic variation in the growth hormone synthesis pathway in relation to circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3, and breast cancer risk: results from the European prospective investigation into cancer and nutrition study.
07/2005Long-term cryoconservation and stability of vitamin C in serum samples of the European prospective investigation into cancer and nutrition.
06/2005C-peptide, IGF-I, sex-steroid hormones and adiposity: a cross-sectional study in healthy women within the European Prospective Investigation into Cancer and Nutrition (EPIC).
04/2005Fibrinogen and cigarette smoking in men and women in the European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population.
01/2005Phytoestrogen exposure correlation with plasma estradiol in postmenopausal women in European Prospective Investigation of Cancer and Nutrition-Norfolk may involve diet-gene interactions.
11/2004Blood pressure and urinary sodium in men and women: the Norfolk Cohort of the European Prospective Investigation into Cancer (EPIC-Norfolk).
09/2004Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk.
09/2004Plasma levels of cholesteryl ester transfer protein and the risk of future coronary artery disease in apparently healthy men and women: the prospective EPIC (European Prospective Investigation into Cancer and nutrition)-Norfolk population study.
06/2004Preliminary communication: glycated hemoglobin, diabetes, and incident colorectal cancer in men and women: a prospective analysis from the European prospective investigation into cancer-Norfolk study.
05/2004Phytoestrogen concentrations in serum and spot urine as biomarkers for dietary phytoestrogen intake and their relation to breast cancer risk in European prospective investigation of cancer and nutrition-norfolk.

Articles by Research Topic

Disease

35Neoplasms (Cancer)
10/2008 - 05/2004
13Coronary Artery Disease (Coronary Atherosclerosis)
10/2007 - 08/2004
7Breast Neoplasms (Breast Cancer)
01/2008 - 05/2004
5Endometrial Neoplasms (Endometrial Cancer)
06/2008 - 01/2007
5Prostatic Neoplasms (Prostate Cancer)
05/2008 - 01/2006
3Coronary Disease (Coronary Heart Disease)
06/2008 - 01/2007
2Colorectal Neoplasms (Colorectal Cancer)
10/2008 - 06/2004
2Stroke (Strokes)
01/2008 - 02/2007
2Cardiovascular Diseases (Cardiovascular Disease)
12/2007 - 09/2004
2Ovarian Neoplasms (Ovarian Cancer)
03/2007 - 01/2007
2Stomach Neoplasms (Stomach Cancer)
12/2006 - 11/2006
1Gallstones (Gallstone)
01/2008
1Syndrome
09/2007
1Rectal Neoplasms (Rectal Cancer)
07/2007
1Lung Neoplasms (Lung Cancer)
12/2006
1Adenocarcinoma
05/2006

Drug/Important Bio-Agent (IBA)

5Phytoestrogens (Phytoestrogen)IBA
10/2008 - 05/2004
5Ascorbic Acid (Vitamin C)FDA LinkGeneric
01/2008 - 07/2005
4Hemoglobins (Hemoglobin)IBA
06/2008 - 06/2004
4C-PeptideIBA
07/2007 - 06/2005
3Gonadal Steroid Hormones (Sex Hormones)IBA
06/2008 - 06/2005
3Insulin-Like Growth Factor I (IGF-1)IBA
03/2007 - 06/2005
3C-Reactive ProteinIBA
12/2006 - 08/2006
2Biological Markers (Surrogate Marker)IBA
01/2008 - 05/2004
2AndrogensIBA
09/2007 - 01/2007
2Lipoproteins (Lipoprotein)IBA
09/2007 - 02/2007
2Insulin-Like Growth Factor Binding Protein 1IBA
07/2007 - 06/2007
2Insulin-Like Growth Factor Binding Protein 2IBA
07/2007 - 06/2007
2Triglycerides (Triacylglycerol)IBA
01/2007 - 09/2006
1Dietary Fats (Ghee)IBA
05/2008
1Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric
02/2008
1Testosterone (Sustanon)FDA LinkGeneric
12/2007
1CholesterolIBA
11/2007
1Apolipoprotein A-II (Apolipoprotein A2)IBA
10/2007
1Dietary Carbohydrates (Carbohydrate, Dietary)IBA
10/2007
1Vitamin A (Retinol)FDA Link
09/2007
1Glucose (Dextrose)FDA LinkGeneric
09/2007
1TocopherolsFDA Link
09/2007
1Carotenoids (Carotene)IBA
09/2007
1Peroxidase (Myeloperoxidase)IBA
07/2007
1Carrier Proteins (Binding Protein)IBA
03/2007
1Acetyl-CoA CarboxylaseIBA
03/2007
1Phytosterols (Plant Sterols)IBA
01/2007
1AdiponectinIBA
01/2007
1SmokeIBA
12/2006
1Ethanol (Ethyl Alcohol)IBA
12/2006
1Mannose-Binding Lectin (Mannan-Binding Lectin)IBA
10/2006
1IsoflavonesIBA
09/2006
1Sex Hormone-Binding GlobulinIBA
09/2006
1Apoprotein(a) (Apolipoprotein (a))IBA
09/2006
1SteroidsIBA
06/2006
1Cytochrome P-450 CYP2E1 (CYP2E1)IBA
05/2006
1Lipoprotein Lipase (Diacylglycerol Lipase)IBA
03/2006
1Aromatase (CYP19)IBA
01/2006
1Growth Hormone (Somatotropin)IBA
10/2005
1Insulin (Novolin)FDA Link
10/2005
1Secretory Phospholipases A2IBA
04/2005
1Fibrinogen (Factor I)IBA
04/2005
1Estradiol (Estrace)FDA LinkGeneric
01/2005
1SodiumIBA
11/2004
1Cholesterol Ester Transfer ProteinsIBA
09/2004
1Interleukin-8 (Interleukin 8)IBA
08/2004

Therapy/Procedure

1Hormone Replacement Therapy (Therapy, Hormone Replacement)
01/2008